Skip to content

Study · Animal study (in vivo) · rat · 1987

2 results

[Effect of vitamin E and thymalin on the development of experimental allergic encephalomyelitis].

Vilkov GA, Stepanenko EM, Kryzhanovskiĭ GN

Biulleten' eksperimental'noi biologii i meditsiny1 Sept 1987Cited by 1 (Europe PMC)

PMID3663910 (opens in a new tab)DOI10.1007/bf00841993 (opens in a new tab)PepBankPUB-03663910
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats resistant to encephalomyelitis, thymaline administration prevented disease onset.

    In plain wordsIn rats resistant to encephalomyelitis, thymaline prevented disease onset.

    Peptide
    Thymalin
    Outcome
    DecreaseEncephalomyelitis onset
    Study

    ratn: not reported in source

    Rats resistant to encephalomyelitis
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    It has been established in the experiments on rats resistant to encephalomyelitis that vitamin E deficiency promoted and thymaline administration prevented the onset of the disease.

Studies that did not test the peptide alone1

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 02AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In susceptible guinea-pigs, alpha-tocopherol with thymaline prevented encephalomyelitis development.

    In plain wordsIn guinea-pigs susceptible to encephalomyelitis, alpha-tocopherol with thymaline prevented disease development.

    Peptide
    Thymalin
    Outcome
    DecreaseEncephalomyelitis onset
    Study

    guinea pign: not reported in source

    Guinea-pigs sensitive to encephalomyelitis
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    The experiments on guinea-pigs sensitive to encephalomyelitis have shown that the combined administration of alpha-tocopherol and thymaline prevented the development of the disease.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.